Evaluation of major parameters of cardiovascular dysfunction concerning ANGPTL2 and ANGPTL3, especially in a cohort design, is highly recommended for future research to establish the connection between these markers and risk of cardiovascular diseases that generally accompany obesity. This evidence concerns the gene ANGPTL2 and obesity disorder.